GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases

Clinical trial NCT07122076 · RECRUITING

Trial details

NCT number: NCT07122076
Sponsor: Grit Biotechnology
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2025-08-22
Primary completion: 2028-08-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.